Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?

Simple item page
dc.contributor.authorİnanç, Nevsun
dc.contributor.authorÖzen, Gülşen
dc.contributor.authorYalçınkaya, Yasemin
dc.contributor.authorKoca, Süleyman Serdar
dc.contributor.authorCan, Gerçek
dc.contributor.authorKarataş, Ahmet
dc.contributor.authorYazıcı, Ayten
dc.contributor.authorCefle, Ayşe
dc.contributor.authorTufan, Abdurrahman
dc.contributor.authorAkar, Servet
dc.contributor.authorŞenel, Soner
dc.contributor.authorÖz, Burak
dc.contributor.authorAkkoç, Nurullah
dc.contributor.authorÖnen, Fatoş
dc.contributor.buuauthorDalkılıç, Ediz
dc.contributor.buuauthorPehlivan, Yavuz
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Romatoloji Anabilim Dalı.tr_TR
dc.contributor.researcheridCMF-4757-2022tr_TR
dc.contributor.researcheridAAG-8227-2021tr_TR
dc.date.accessioned2023-08-24T07:15:06Z
dc.date.available2023-08-24T07:15:06Z
dc.date.issued2017-10
dc.identifier.citationİnanç, N. vd. (2017). ''Is there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?''. Arthritis & Rheumatology, 69(Supplement 10).en_US
dc.identifier.isbn2326-5205
dc.identifier.issn2326-5191
dc.identifier.issueSupplement 10en_US
dc.identifier.urihttps://acrjournals.onlinelibrary.wiley.com/loi/23265205
dc.identifier.urihttp://hdl.handle.net/11452/33609
dc.identifier.volume69tr_TR
dc.identifier.wos000411824100541tr_TR
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherWileyen_US
dc.relation.collaborationYurt içitr_TR
dc.relation.journalArthritis & Rheumatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectRheumatologyen_US
dc.subject.wosRheumatologyen_US
dc.titleIs there any difference in ra patients for methotrexate use vs. leflunomide use as a concomitant treatment with biological and targeted synthetic dmards in turkbio registry?en_US
dc.typeMeeting Abstract
dc.wos.quartileQ1en_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Web of Science